KMT2C.md
... ...
@@ -32,16 +32,8 @@ timeline
32 32
33 33
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
34 34
35
-|Entity|source |frequency (%)|
36
-|:------:|:---------------------:|:-------------:|
37
-|DLBCL |GAMBL genomes |3.25 |
38
-|DLBCL |Schmitz cohort |8.30 |
39
-|DLBCL |Reddy cohort |7.31 |
40
-|DLBCL |Chapuy cohort |6.41 |
41
-|BL |GAMBL genomes+capture|6.47 |
42
-|BL |Thomas cohort | NA |
43
-|BL |Panea cohort | NA |
44
-|MCL |GAMBL genomes |0.47 |
35
+[[include:DLBCL_KMT2C.md]]
36
+[[include:BL_KMT2C.md]]
45 37
46 38
## Mutation pattern and selective pressure estimates
47 39
KRAS.md
... ...
@@ -24,12 +24,7 @@ timeline
24 24
25 25
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
26 26
27
-|Entity|source |frequency (%)|
28
-|:------:|:--------------:|:-------------:|
29
-|DLBCL |GAMBL genomes |1.91 |
30
-|DLBCL |Schmitz cohort|3.62 |
31
-|DLBCL |Reddy cohort |1.70 |
32
-|DLBCL |Chapuy cohort |2.56 |
27
+[[include:DLBCL_KRAS.md]]
33 28
34 29
## Mutation pattern and selective pressure estimates
35 30